Pegfeel 6mg Injection

Pegfeel 6mg Injection contains peglylated granulocyte colony-stimulating factor as its active ingredient. This protein is synthesised from the bacterium E. coli and belongs to the cytokine family, functioning similarly to the natural protein produced by the body. It is a leukocyte growth factor indicated to reduce infections in patients receiving anti-cancer drugs with bone marrow suppressive properties. By reducing infection risk, Pegfeel 6mg Injection enables cancer patients to receive their full chemotherapy dose on schedule, thereby improving treatment outcomes. This medication is also prescribed to increase survival in patients exposed to radiotherapy. Patients receiving Pegfeel 6mg Injection may experience reduced fatigue, fewer days of fever and infection, and shorter hospital stays. This can contribute to improved quality of life during cancer treatment. This medication may interfere with bone marrow function testing, including aspiration and biopsy, and can produce false-positive results. Patients should inform their healthcare provider of their use of Pegfeel 6mg Injection before undergoing any bone marrow function testing.

Pegfeel 6mg Injection is used in treating the following: Chemotherapy-induced neutropenia Chemotherapy-induced fever Chemotherapy-induced infections

The therapeutic effect of Pegfeel 6mg Injection is to stimulate the production of neutrophils in the bone marrow. Neutrophils are a type of white blood cell that help to fight infections. Chemotherapy drugs can cause damage to the bone marrow, leading to a decrease in the number of neutrophils, which can increase the risk of infections. So this medication works by stimulating the bone marrow to produce more neutrophils, which can help prevent infections in cancer patients undergoing chemotherapy. This can reduce the risk of infections, hospitalizations, and other complications associated with chemotherapy-induced neutropenia.

Pegfeel 6mg Injection is administered as an injection under the skin. The injection should be given in the abdomen (at least 2 inches away from the belly button), the front of the thighs, or the upper arm. It is usually administered once per chemotherapy cycle. The medication should be administered at least 24 hours after the last dose of chemotherapy to allow for proper bone marrow recovery.

Like all medications, Pegfeel 6mg Injection causes some side effects, although not everyone will experience them. Serious: Allergic reactions Acute respiratory distress syndrome (ARDS) Splenic rupture Kidney damage Interstitial lung disease (ILD) Common: Bone pain Headache Fatigue Muscle aches Nausea Vomiting Diarrhea Loss of appetite Injection site reactions

Remember always to follow your healthcare provider's instructions when taking Pegfeel 6mg Injection or any medication. Patients should be monitored for signs of an allergic reaction, such as rash, itching, or swelling, and should seek immediate medical attention if these symptoms occur. If you have any questions or concerns, do not hesitate to discuss them with your healthcare provider. Be aware of potential side effects and notify your healthcare provider if you experience any unusual symptoms. It should be used with caution in patients with severe renal impairment. Pregnant and breastfeeding women should discuss potential risk and benefit with a healthcare provider before taking this medication. Always maintain a healthy and balanced diet to support your overall health and well-being.